These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30874605)

  • 41. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
    Lue LF; Walker DG
    J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglial immunophenotype in dementia with Alzheimer's pathology.
    Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
    J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
    van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
    Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
    Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
    Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway.
    Perea JR; Ávila J; Bolós M
    Exp Neurol; 2018 Dec; 310():14-21. PubMed ID: 30138606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.
    Walker DG; Lue LF; Beach TG; Tooyama I
    Cells; 2019 Jul; 8(7):. PubMed ID: 31340569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
    Nobuhara CK; DeVos SL; Commins C; Wegmann S; Moore BD; Roe AD; Costantino I; Frosch MP; Pitstick R; Carlson GA; Hock C; Nitsch RM; Montrasio F; Grimm J; Cheung AE; Dunah AW; Wittmann M; Bussiere T; Weinreb PH; Hyman BT; Takeda S
    Am J Pathol; 2017 Jun; 187(6):1399-1412. PubMed ID: 28408124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
    J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anesthetic sevoflurane induces tau trafficking from neurons to microglia.
    Dong Y; Liang F; Huang L; Fang F; Yang G; Tanzi RE; Zhang Y; Quan Q; Xie Z
    Commun Biol; 2021 May; 4(1):560. PubMed ID: 33980987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
    Sankaranarayanan S; Barten DM; Vana L; Devidze N; Yang L; Cadelina G; Hoque N; DeCarr L; Keenan S; Lin A; Cao Y; Snyder B; Zhang B; Nitla M; Hirschfeld G; Barrezueta N; Polson C; Wes P; Rangan VS; Cacace A; Albright CF; Meredith J; Trojanowski JQ; Lee VM; Brunden KR; Ahlijanian M
    PLoS One; 2015; 10(5):e0125614. PubMed ID: 25933020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.
    Asuni AA; Boutajangout A; Quartermain D; Sigurdsson EM
    J Neurosci; 2007 Aug; 27(34):9115-29. PubMed ID: 17715348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions.
    Pandit R; Leinenga G; Götz J
    Theranostics; 2019; 9(13):3754-3767. PubMed ID: 31281511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
    Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
    Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model.
    Münster Y; Keyvani K; Herring A
    Exp Neurol; 2020 Feb; 324():113115. PubMed ID: 31734318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
    Spangenberg EE; Green KN
    Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.